Bio Rad Laboratories Stock Price - BIO.B

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Bio Rad Laboratories Inc BIO.B NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -4.86 -1.28% 375.44 375.44 375.44 375.44 380.30 16:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8 101 $ 375.44 $ 37,919 1,106 234.25 - 383.66
Last Trade Time Type Quantity Stock Price Currency
18:30:00 100 $ 375.44 USD

Bio Rad Laboratories Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 11.24B 29.93M $ 365.61M 12.13 29.60 24.66M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.00 $ - 0.00% 6.00 17.60%

more financials information »

Bio Rad Laboratories News

Loading Messages....

Latest BIO.B Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIO.B Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week378.565383.66375.44382.3268-3.13-0.83%
1 Month361.96383.66361.96369.741,96213.483.72%
3 Months341.43383.66341.43368.0376234.019.96%
6 Months308.78383.66307.28362.5041766.6621.59%
1 Year237.9966383.66234.25348.22290137.4457.75%
3 Years182.65383.66182.65287.29398192.79105.55%
5 Years117.38383.66114.48246.98235258.06219.85%

Bio Rad Laboratories Description

Bio-Rad Laboratories manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe.


Your Recent History
NYSE
BIO.B
Bio Rad La..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.